SOURCE: Xtalks

Xtalks Webinars

April 14, 2016 07:00 ET

Assessing Cognitive Safety of Drugs in Clinical Development, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - April 14, 2016) - Cognitive impairment is increasingly recognized as a serious potential side effect of medication -- both for central nervous system (CNS) and non-CNS compounds. Despite concerns voiced by physicians, regulators and consumers many drug development programs do not incorporate objective and sensitive cognitive assessments as part of the clinical characterization and decision-making process. Additionally, cognitive assessment is an essential tool for clinical trial research professionals for the evaluation of efficacy of many new medications being developed to address devastating diseases, including Alzheimer's, depression, schizophrenia and ADHD.

Key Discussion Points:

  • What is cognition and how is it best measured throughout the drug development process for both CNS and non-CNS indications?
  • Why monitor cognition in drug development?
  • Are there current or upcoming regulations that impact cognition assessment?
  • What are desirable characteristics of cognitive assessment tools?
  • What developments are on the horizon for cognitive assessment?

Spend 60 minutes with two industry experts and walk away with a firm understanding of:

  • Why there is a need to assess cognitive safety in clinical development of compounds
  • Methodological considerations for cognitive assessment in clinical trials
  • Approaches to the analysis and interpretation of cognitive outcome measures and how current state-of-the-art cognitive assessment technology can be incorporated into the clinical development process to facilitate early decision making
  • How to evaluate cognitive efficacy, profile safety and tolerability and satisfy regulatory requirements in an increasingly challenging and competitive pharmaceutical landscape

Join inVentiv Health for this informative session on Thursday, April 28, 2016 at 11am EDT (4pm BST/UK). To learn more visit: Assessing Cognitive Safety of Drugs in Clinical Development.

About inVentiv Health

inVentiv Health is a leading global provider of outsourced clinical development and commercialization services to biopharmaceutical companies.

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, health care centers, etc.) turn to Xtalks for access to quality content. Xtalks helps life science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.

Image Available: http://www.marketwire.com/library/MwGo/2016/4/13/11G093312/Images/inVentivHealth_rgb-280646358745.jpg

Contact Information